MedicineAll countries · Checked
GLP-1 Drugs Explained: Every GLP-1 Medication, Price and Dose in One Place
GLP-1 drugs copy a gut hormone that your body releases after you eat. As of November 2026, they come as injections (semaglutide, tirzepatide and liraglutide) and as three daily pills (the Wegovy pill, Rybelsus and Foundayo). The Wegovy pill and Foundayo are approved in both the US and the UK.
GLP-1 drugs at a glance
Injections are weekly or daily. Pills are daily.
Once-weekly injectionWegovy, Ozempic, Mounjaro, Zepbound
Once-daily injectionSaxenda, Victoza
Once-daily pillWegovy pill, Rybelsus, Foundayo
Which of them is approved, and for what, depends on the country.
Want the monthly cost first?
See the monthly price of each GLP-1 drug in the USPrices in the UK and India are on their own pages.
What it isDrug listPillsInjectionsResultsSide effectsPriceGenericNew drugsFAQ
What is GLP-1?
GLP-1 is a hormone your gut releases after a meal. The natural version breaks down in about 1.5 to 2 minutes, so the medicines use longer-lasting copies. That is why one shot can last a day or a week.
These drugs switch on the GLP-1 receptor and slow how fast your stomach empties. Tirzepatide also switches on a second hormone receptor, GIP.
Every medicine below is a prescription product approved by a regulator such as the FDA, the EMA or the MHRA.
GLP-1 drugs list
Semaglutide, made by Novo Nordisk, is sold as Wegovy for weight loss and Ozempic for type 2 diabetes. Both are once-weekly injections. Semaglutide for weight loss compares the brands.
Tirzepatide, made by Eli Lilly, is Mounjaro and Zepbound. In the US, Mounjaro is the diabetes brand and Zepbound the weight-loss brand. In the UK and the EU, Mounjaro covers both. Read about Mounjaro and Zepbound.
Liraglutide is the older daily injection: Saxenda for weight loss and Victoza for diabetes. See liraglutide (Saxenda).
In the US, Ozempic is labeled for type 2 diabetes. It also lowers the risk of heart events in people with diabetes and heart disease, and of kidney decline in people with diabetes and kidney disease.
Brands by medicine
SemaglutideWegovy, Ozempic, Rybelsus
TirzepatideMounjaro, Zepbound
LiraglutideSaxenda, Victoza
OrforglipronFoundayo
GLP-1 pills
Three daily GLP-1 pills are on the US market: the Wegovy pill, Rybelsus and Foundayo. The UK regulator, the MHRA, has also approved the Wegovy pill (June 11, 2026) and Foundayo (August 10, 2026), but neither is on the NHS yet. Only the Wegovy pill and Foundayo are labeled for weight loss. Rybelsus is the semaglutide pill for type 2 diabetes.
The Wegovy pill starts at 1.5 mg for 30 days, then 4 mg and 9 mg for 30 days each, and reaches 25 mg from day 91. You take it first thing in the morning on an empty stomach with up to 4 ounces of plain water, then wait at least 30 minutes before eating.
Foundayo (orforglipron) is Lilly's pill, first approved in the US in 2026. It starts at 0.8 mg once a day, moves up after at least 30 days on each dose, and tops out at 17.2 mg. You can take it with or without food. See Foundayo doses and price and the Wegovy pill.
GLP-1 injections
All the injections go under the skin. Wegovy, Ozempic, Mounjaro and Zepbound are once a week, while Saxenda and Victoza are once a day.
Wegovy starts at 0.25 mg for four weeks, then steps through 0.5, 1 and 1.7 mg at four weeks each. The usual maintenance dose is 2.4 mg. Mounjaro and Zepbound start at 2.5 mg and top out at 15 mg. Saxenda is built up to 3 mg a day.
Dose steps and missed-dose rules differ for every drug, so each has its own chart. Start with the GLP-1 dosage chart.
GLP-1 weight loss results
Each drug has its own big trial, and the trials differ in length and in who joined. All of these are trial averages, not a promise for any one person.
Wegovy shot, 68 weeks−14.9%Wegovy pill, 64 weeks−13.6%Tirzepatide 15 mg, 72 weeks−20.9%
The placebo groups lost 2.4% in the Wegovy shot trial, 2.4% in the Wegovy pill trial and 3.1% in the tirzepatide trial.
Foundayo lost an average of 11.1% on 17.2 mg, 8.3% on 9 mg and 7.4% on 5.5 mg over 72 weeks, against 2.1% on placebo. Saxenda lost 7.4% over 56 weeks, against 3.0% on placebo.
Everyone in these trials also had diet and activity advice. Trials in adults with type 2 diabetes show smaller losses.
GLP-1 side effects
The most common side effects are in the gut: nausea, diarrhea, vomiting, constipation and stomach pain.
In the Wegovy injection trials, nausea affected 44% of adults (16% on placebo), diarrhea 30% (16%), vomiting 24% (6%) and constipation 24% (11%).
The semaglutide, tirzepatide and liraglutide labels carry a boxed warning on thyroid C-cell tumors, seen in rodents and not shown in people. You cannot use them if you or your family have had medullary thyroid cancer or MEN 2.
Two GLP-1 medicines are not taken together, so a switch from one to another is your prescriber's call.
GLP-1 price and coverage
Prices swing with the country, the drug, the dose and your insurance, so the numbers live on the country pages.
Check weight loss injections on the NHS in the UK, or GLP-1 without insurance in the US.
Want to work out your own monthly cost?
Calculate your GLP-1 cost and dose scheduleThe tool also keeps a weight log.
Generic GLP-1 drugs
Whether a generic exists depends on the ingredient and the country. The answer for each medicine is in generic GLP-1 drugs.
New GLP-1 drugs
Drugs that are not yet approved have their own pages: survodutide, CagriSema and eloralintide and amycretin.
Approvals and trial dates are tracked in new weight loss drugs, and the latest headlines are in GLP-1 news.
GLP-1 FAQ
What are the GLP-1 drugs?
Semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda, Victoza) and orforglipron (Foundayo).
Is there a GLP-1 pill?
Yes. The US has the Wegovy pill, Rybelsus and Foundayo. The Wegovy pill and Foundayo are the two labeled for weight loss.
How often do you take a GLP-1 drug?
Wegovy, Ozempic, Mounjaro and Zepbound once a week. Saxenda, Victoza and all the pills once a day.
Which GLP-1 drug has the biggest weight loss?
In the trials above, tirzepatide 15 mg lost the most, at 20.9% over 72 weeks. The trials ran for different lengths with different people, so the numbers are not a head-to-head result.
Can you get a GLP-1 drug without diabetes?
Yes. Wegovy, Zepbound, Saxenda and Foundayo are labeled for adults with obesity, or with overweight and at least one weight-related condition. Your prescriber decides.
Keep reading
Weight loss injection prices in the UK
This page follows official product information and regulator notices and is updated when they change. See how we check our pages.
Update log
: First published.
Sources
U.S. Food and Drug Administration, Wegovy injection and tablets prescribing information.
U.S. Food and Drug Administration, Foundayo prescribing information.
U.S. Food and Drug Administration, Saxenda prescribing information.
U.S. Food and Drug Administration, Ozempic prescribing information.
Eli Lilly, Zepbound US prescribing information.
GLP1 Note is an independent information site. Which medicine and dose suit you is for your prescriber to decide.